Drägerwerk AG & Co. KGaA EV/EBITDA
What is the EV/EBITDA of Drägerwerk AG & Co. KGaA?
The EV/EBITDA of Drägerwerk AG & Co. KGaA is 21.22
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on XETRA compared to Drägerwerk AG & Co. KGaA
What does Drägerwerk AG & Co. KGaA do?
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, and system products. Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, professional diving equipment and systems, and alcohol and drug testing devices. In addition, the company offers various training and services, as well as undertakes projects that include fire training systems. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Companies with ev/ebitda similar to Drägerwerk AG & Co. KGaA
- Mondelez Intl A has EV/EBITDA of 21.19
- Spirax-Sarco Engineering Plc has EV/EBITDA of 21.20
- Kirloskar Ferrous Industries has EV/EBITDA of 21.20
- BGR Systems has EV/EBITDA of 21.20
- Marathon Nextgen Realty has EV/EBITDA of 21.20
- China Mengniu Dairy has EV/EBITDA of 21.22
- Drägerwerk AG & Co. KGaA has EV/EBITDA of 21.22
- Lifestyle China has EV/EBITDA of 21.23
- Waste Connections has EV/EBITDA of 21.23
- China Innovation Investment has EV/EBITDA of 21.24
- AURELIUS Equity Opportunities SE & Co. KGaA has EV/EBITDA of 21.24
- LifeTech Scientific has EV/EBITDA of 21.24
- Slate Retail REIT has EV/EBITDA of 21.24